Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Public companies are Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) biggest owners and were rewarded after market cap rose by US$137m last week [Yahoo! Finance]
Gyre Therapeutics: Under The Radar Biotech Has A Shot At MASH Approval, In Time [Seeking Alpha]
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]